1. Home
  2. EDD vs NBY Comparison

EDD vs NBY Comparison

Compare EDD & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morgan Stanley Emerging Markets Domestic Debt Fund Inc.

EDD

Morgan Stanley Emerging Markets Domestic Debt Fund Inc.

N/A

Current Price

$5.54

Market Cap

397.7M

Sector

Finance

ML Signal

N/A

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

N/A

Current Price

$1.21

Market Cap

398.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
EDD
NBY
Founded
2007
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
397.7M
398.2M
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
EDD
NBY
Price
$5.54
$1.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
475.3K
844.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
7.52%
N/A
EPS Growth
N/A
35.42
EPS
N/A
0.76
Revenue
N/A
$370,000.00
Revenue This Year
N/A
$23.91
Revenue Next Year
N/A
$32.05
P/E Ratio
N/A
$1.67
Revenue Growth
N/A
N/A
52 Week Low
$4.28
$0.43
52 Week High
$6.18
$19.95

Technical Indicators

Market Signals
Indicator
EDD
NBY
Relative Strength Index (RSI) 29.64 41.58
Support Level $5.45 $0.99
Resistance Level $5.69 $1.36
Average True Range (ATR) 0.10 0.26
MACD -0.06 0.16
Stochastic Oscillator 19.29 5.33

Price Performance

Historical Comparison
EDD
NBY

About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.

Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: